L3VLUP
ProSign in

XRAY in the 13F filings

Dentsply Sirona Inc · CUSIP 24906P109

Sector · Medical devices and instrumentsTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Surgical, medical and electromedical devices
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
31 Dec 2023
the date the book describes
Filed
16 Feb 2024
latest of these filings; the earliest 17 Jan 2024
Managers listing it
13
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q3 2023 and Q4 2023; 9 listed it in both
Shares listed
46,885,610
combined, among listed positions
Reported value
$1.7bn
combined, at the quarter end

Among the 93 comparable managers: 9 buyers (opened or added shares) and 7 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing XRAY in Q4 2023

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q3 2023, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

13 of 13 holders

ActionFiling
Artisan Partners LP12,944,034$461m0.71%Added+8,72012 Feb 2024 (the filing on sec.gov)
First Eagle Investment Management LLC9,786,845$348m0.83%Added+120,5088 Feb 2024 (the filing on sec.gov)
Wellington Management Group LLP8,138,253$290m0.05%Added+1,419,50312 Feb 2024 (the filing on sec.gov)
Janus Henderson Group Ltd7,583,187$270m0.16%Added+157,84814 Feb 2024 (the filing on sec.gov)
T. Rowe Price Associates Inc5,922,866$211munder 0.1%Trimmed-156,36716 Feb 2024 (the filing on sec.gov)
Marshall Wace LLP1,147,056$41m0.07%Newnew14 Feb 2024 (the filing on sec.gov)
Arrowstreet Capital LP411,509$15munder 0.1%Trimmed-795,13414 Feb 2024 (the filing on sec.gov)
Bridgewater Associates LP326,488$12m0.07%Trimmed-39,95014 Feb 2024 (the filing on sec.gov)
Winton Group Ltd240,800$8.6m0.62%Newnew12 Feb 2024 (the filing on sec.gov)
ExodusPoint Capital Management LP164,855$5.9munder 0.1%Addedn.a.14 Feb 2024 (the filing on sec.gov)
ARK Investment Management LLC118,415$4.2munder 0.1%Trimmed-9,82717 Jan 2024 (the filing on sec.gov)
GAMCO Investors Inc66,394$2.4munder 0.1%Added+6,10014 Feb 2024 (the filing on sec.gov)
Quantbot Technologies LP34,908$1.2m0.07%Newnew14 Feb 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q3 2023 to Q4 2023, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (3)

Exited (3)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
8 in Q3 2024 to 5 in Q2 2026

Tracked managers listing it, at least.

010203020162017201820192020202120222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
XRAY by quarter
QuarterHoldersReported valueBuyersSellers
Q1 201617$3.1bnn.a.n.a.
Q2 201618$3.0bnn.a.n.a.
Q3 201615$2.8bnn.a.n.a.
Q4 201614$2.7bnn.a.n.a.
Q1 201719$2.7bnn.a.n.a.
Q2 201713$2.6bnn.a.n.a.
Q3 201713$2.6bnn.a.n.a.
Q4 201712$2.6bnn.a.n.a.
Q1 201817$1.4bnn.a.n.a.
Q2 201812$933mn.a.n.a.
Q3 201818$1.6bnn.a.n.a.
Q4 201813$1.6bnn.a.n.a.
Q1 201913$1.8bnn.a.n.a.
Q2 201914$2.1bnn.a.n.a.
Q3 201916$1.9bnn.a.n.a.
Q4 201916$2.0bnn.a.n.a.
Q1 202016$1.5bnn.a.n.a.
Q2 202016$2.1bnn.a.n.a.
Q3 202014$2.3bnn.a.n.a.
Q4 202011$2.7bnn.a.n.a.
Q1 202116$3.7bnn.a.n.a.
Q2 202123$3.8bnn.a.n.a.
Q3 202118$3.3bnn.a.n.a.
Q4 202113$2.8bnn.a.n.a.
Q1 202216$2.8bnn.a.n.a.
Q2 202218$2.0bnn.a.n.a.
Q3 202217$1.5bnn.a.n.a.
Q4 202214$1.6bnn.a.n.a.
Q1 202311$2.2bnn.a.n.a.
Q2 202310$1.9bnn.a.n.a.
Q3 202315$1.7bnn.a.n.a.
Q4 202313$1.7bn97
Q1 202412$1.1bn85
Q2 20249$781m73
Q3 20248$941m62
Q4 20249$648m82
Q1 20259$586m82
Q2 20258$639m36
Q3 20256$369m42
Q4 20255$199m239
Q1 20267$273m1717
Q2 20265$61m1019

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

XRAY and LLY →XRAY and JNJ →XRAY and VRTX →Choose a stock to compare with XRAY →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own XRAY, latest filings →Back to the 13F Explorer →